Compare Clover Health Investments Corp. with Similar Stocks
Dashboard
1
Strong Long Term Fundamental Strength with a 73.00% CAGR growth in Net Sales
2
Healthy long term growth as Net Sales has grown by an annual rate of 73.00%
3
With a growth in Net Sales of 53.61%, the company declared Very Positive results in Mar 26
4
Risky -
5
High Institutional Holdings at 34.4%
6
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
165.96%
0%
165.96%
6 Months
93.8%
0%
93.8%
1 Year
68.35%
0%
68.35%
2 Years
354.55%
0%
354.55%
3 Years
454.2%
0%
454.2%
4 Years
125.23%
0%
125.23%
5 Years
-58.47%
0%
-58.47%
Clover Health Investments Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
73.00%
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
34.40%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.15
EV to EBIT
NA
EV to EBITDA
504.67
EV to Capital Employed
4.52
EV to Sales
0.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
ROE (Latest)
-27.71%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 32 Schemes (12.97%)
Foreign Institutions
Held by 91 Foreign Institutions (4.16%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
0.50
0.40
25.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
27.30
-49.30
155.38%
Operating Profit Margin (Excl OI)
36.50%
-101.10%
13.76%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 155.38% vs -102.05% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
1.70
1.30
30.77%
Interest
0.00
0.00
Exceptional Items
0.00
-0.30
100.00%
Consolidate Net Profit
-85.50
-46.30
-84.67%
Operating Profit Margin (Excl OI)
-44.50%
-33.50%
-1.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -84.67% vs 77.96% in Dec 2024
About Clover Health Investments Corp. 
Clover Health Investments Corp.
Insurance
No Details Available.
Company Coordinates 
No Company Details Available






